IA
BBIO icon

Inspire Advisors’s BridgeBio Pharma BBIO Stock Holding History

Inspire Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Sell
3,788
-1,855
-33% -$130K 0.02% 553
2026
Q1 		$419K Sell
5,643
-665
-11% -$48.2K 0.03% 403
2025
Q4 		$483K Sell
6,308
-6,234
-50% -$409K 0.04% 343
2025
Q3 		$651K Buy
+12,542
New +$612K 0.06% 247

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Inspire Advisors's BBIO Position: Q2 2026 in Review

Inspire Advisors reduced its BridgeBio Pharma (BBIO) stake by 33% in Q2 2026, selling an estimated $130K and leaving 3,788 shares worth $282K. The position accounts for 0.02% of the portfolio, ranked #553.

Inspire Advisors first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $651K in Q3 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Inspire Advisors held 3,788 shares of BridgeBio Pharma worth $282K as of Q2 2026.
  • Inspire Advisors sold 1,855 BridgeBio Pharma shares in Q2 2026, an estimated $130K.
  • BridgeBio Pharma made up 0.02% of Inspire Advisors's portfolio in Q2 2026, its #553 holding.
  • Inspire Advisors first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
  • Inspire Advisors's BridgeBio Pharma position peaked at $651K in Q3 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.